Lexatumumab
Showing 1 - 11 of 11
Ewing's Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Lexatumumab alone, Lexatumumab in combination, Interferon
Terminated
- Ewing's Sarcoma
- +3 more
- Lexatumumab alone
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston
Completed
- Cholangiocarcinoma
- +11 more
- Laboratory Biomarker Analysis
- Ramucirumab
-
Houston, TexasM D Anderson Cancer Center
Jul 7, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Sep 7, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Nov 30, 2022
Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta
Recruiting
- Metastatic Non-Small Lung Cell Cancer
- +4 more
- Docetaxel
- +2 more
-
Atlanta, GeorgiaWinship Cancer Institute of Emory University
Oct 19, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Pembrolizumab
- Ramucirumab
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 22, 2021
Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Esophageal Carcinoma
- +12 more
- Olaparib
- Ramucirumab
-
Corona, California
- +31 more
Aug 9, 2022
Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage III Gastric Cancer AJCC v8
- +30 more
- Paclitaxel
- +3 more
-
Scottsdale, Arizona
- +11 more
Apr 4, 2022
Locally Advanced Thymic Carcinoma, Metastatic Thymic Carcinoma, Recurrent Thymic Carcinoma Trial in United States (Carboplatin,
Recruiting
- Locally Advanced Thymic Carcinoma
- +3 more
- Carboplatin
- +2 more
-
Anchorage, Alaska
- +253 more
Jan 6, 2022
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Berkeley
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Cobalamin
- +8 more
-
Birmingham, Alabama
- +349 more
Oct 18, 2022
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung
Recruiting
- Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
- +7 more
- Cabozantinib S-malate
- +6 more
-
Birmingham, Alabama
- +592 more
Aug 23, 2022